6533b827fe1ef96bd1286b84

RESEARCH PRODUCT

A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes.

Manfredi RizzoGiuseppe MontaltoA PattiV Di BartoloRv GiglioA. Rizvi

subject

liraglutide atherosclerosis type-2 diabeteshttp://hdl.handle.net/10447/197588